Jack van Hulst

Mr. van Hulst is an advisor to SK Capital in the healthcare sector.

Mr. van Hulst spent his career in the pharmaceutical industry, having served as President of Diosynth, owner and CEO of two generic pharmaceutical companies, and EVP of Mova Pharmaceutical Corporation.

He is currently a director and former CEO of Senesco Technologies, and a director of Napo Pharmaceuticals and Hi-Tech Pharmacal.

Mr. van Hulst earned a law degree from the University of Utrecht, The Netherlands.